VGXI Accepted into BARDA-Supported BioMap Consortium
VGXI, Inc., a CDMO specialising in nucleic acid biopharmaceuticals, has announced its acceptance into the Biopharmaceutical Manufacturing Preparedness (BioMap) Consortium. This consortium, supported by the…